Hematological toxicity of combined 177Lu-octreotate radiopeptide chemotherapy of gastroenteropancreatic neuroendocrine tumors in long-term follow-up. [electronic resource]
Producer: 20150720Description: 108-17 p. digitalISSN:- 1423-0194
- Adult
- Aged
- Anemia -- chemically induced
- Antineoplastic Agents -- adverse effects
- Blood Platelets -- drug effects
- Capecitabine
- Dacarbazine -- adverse effects
- Deoxycytidine -- adverse effects
- Digestive System Neoplasms -- drug therapy
- Drug Therapy, Combination
- Female
- Fluorouracil -- adverse effects
- Follow-Up Studies
- Hematologic Diseases -- chemically induced
- Humans
- Incidence
- Intestinal Neoplasms -- drug therapy
- Male
- Middle Aged
- Neuroendocrine Tumors -- drug therapy
- Neutrophils -- drug effects
- Octreotide -- adverse effects
- Pancreatic Neoplasms -- drug therapy
- Radiopharmaceuticals -- adverse effects
- Randomized Controlled Trials as Topic
- Stomach Neoplasms -- drug therapy
- Temozolomide
- Thrombocytopenia -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.